Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019;19(7):525-531.
doi: 10.2174/1566524019666190612135728.

Risk Factor for Residue After Uterine Artery Chemotherapy and Embolization in Combination with Dilatation and Curettage for Treating Caesarean Scar Pregnancy

Feng Cheng  1 , Dan Shan  1 , Sijia Guo  2 , Shuang Cheng  3 , Hongwei Yang  4 , Jialin Han  5 , Tongxiu Hu  1
Affiliations

Risk Factor for Residue After Uterine Artery Chemotherapy and Embolization in Combination with Dilatation and Curettage for Treating Caesarean Scar Pregnancy

Feng Cheng et al. Curr Mol Med. 2019.

Abstract

Objective: We aimed to investigate the potential risk factors for residual lesions after uterine artery chemotherapy and embolization (UACE) in combination with dilatation and curettage (D&C) in patients with cesarean scar pregnancy (CSP).

Settings: Retrospective case-control study.

Method: Univariate analysis and logistic analysis were applied to analyze these data to assess the risk factor of residue after UACE in combination with D&C.

Results: Gestational age, human chorionic gonadotropin (HCG) level, and the gestation sac (GS) evagination to the bladder were the risk factors for the postoperative lesion. The most relevant was GS evagination to the bladder, followed by the preoperative HCG level and the gestational age. We defined the cut-off value of gestational age as 28 days with a sensitivity and specificity of 100 and 0, respectively.

Conclusion: In cases with GS evagination to bladder and HCG of >28,113.65 mIU/ml as well as a gestational age of >28 days, the possibility of residual lesions was high.

Keywords: Caesarean scar pregnancy; dilatation and curettage; residue; risk factors; uterine artery embolization..

PubMed Disclaimer

Figures

Fig. (1)
Fig. (1)
Before embolization of the bilateral uterine artery with gelatin sponge, blood perfusion was left in situ. A. left side; B. right side.
Fig. (2)
Fig. (2)
After embolization of the bilateral uterine artery with gelatin sponge,no blood perfusion was left in situ. A. left side; B. right side.
Fig. (3)
Fig. (3)
Comparison of ROC curves of gestational age and HCG level.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Timor-Tritsch I.E., Monteagudo A. Unforeseen consequences of the increasing rate of cesarean deliveries: early placenta accreta and cesarean scar pregnancy. A review. Am. J. Obstet. Gynecol. 2012;207:14–29. - PubMed
    1. Ko J.K., Li R.H., Cheung V.Y. Caesarean scar pregnancy: a 10-year experience. Aust. N. Z. J. Obstet. Gynaecol. 2015;55:64–69. - PubMed
    1. Sekiguchi A., Okuda N., Kawabata I., Nakai A., Takeshita T. Ultrasound detection of lacunae-like image of a cesarean scar pregnancy in the first trimester. J. Nippon Med. Sch. 2013;80:70–73. - PubMed
    1. Zhuang Y., Huang L. Uterine artery embolization compared with methotrexate for the management of pregnancy implanted within a cesarean scar. Am. J. Obstet. Gynecol. 2009;201:152.e151–152.e153. - PubMed
    1. Seow K.M., Wang P.H., Huang L.W., Hwang J.L. Transvaginal sono-guided aspiration of gestational sac concurrent with a local methotrexate injection for the treatment of unruptured cesarean scar pregnancy. Arch. Gynecol. Obstet. 2013;288:361–366. - PubMed

Publication types

Substances